NEW YORK – Molecular diagnostics firm Genedrive announced Monday its hepatitis C in vitro diagnostic kit received World Health Organization Prequalification.
The HCV ID test will be included in the WHO's list of prequalified diagnostics and becomes eligible to be included in United Nations agencies' procurement processes. The prequalification process includes an independent performance evaluation and site visits to manufacturers.